Skip to content
Homepage
Author:
MyOme, Inc
Posted Date:
May 24, 2026
MyOme Strengthens Board with Appointment of Two Healthcare Leaders
MyOme, Inc
May 24, 2026
MyOme Demonstrates Clinical Validity of Integrated Polygenic and Clinical Risk Prediction for Coronary Artery Disease
MyOme, Inc
May 20, 2026
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
MyOme, Inc
April 30, 2026
